Page last updated: 2024-10-21

isocitric acid and Carcinoma, Embryonal

isocitric acid has been researched along with Carcinoma, Embryonal in 1 studies

isocitric acid: RN given refers to unlabeled parent cpd
isocitric acid : A tricarboxylic acid that is propan-1-ol with a hydrogen at each of the 3 carbon positions replaced by a carboxy group.

Carcinoma, Embryonal: A highly malignant, primitive form of carcinoma, probably of germinal cell or teratomatous derivation, usually arising in a gonad and rarely in other sites. It is rare in the female ovary, but in the male it accounts for 20% of all testicular tumors. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, p1595)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asanagi, M1
Yamada, S1
Hirata, N1
Itagaki, H1
Kotake, Y1
Sekino, Y1
Kanda, Y1

Other Studies

1 other study available for isocitric acid and Carcinoma, Embryonal

ArticleYear
Tributyltin induces G2/M cell cycle arrest via NAD(+)-dependent isocitrate dehydrogenase in human embryonic carcinoma cells.
    The Journal of toxicological sciences, 2016, Volume: 41, Issue:2

    Topics: Apigenin; Carcinoma, Embryonal; cdc25 Phosphatases; Cell Line, Tumor; Cyclin B1; Endocrine Disruptor

2016